Researchers reported new immunology findings implicating CD44+ monocytes in bronchopulmonary dysplasia (BPD) in very premature infants. The work focuses on hyperinflammation in BPD, a chronic lung disease that drives significant neonatal morbidity. By identifying a specific monocyte subset associated with disease-driving inflammation, the study expands the potential target landscape for next-generation neonatal anti-inflammatory strategies. The findings add mechanistic detail that may help refine future biomarker development and therapeutic approaches in preterm lung injury.